Updated:
Ken Capital
Ken Capital is a private equity fund management company under Tigermed. It focuses on investments in CRO M&A and early-stage startups in new drug development.
Overview
Ken Capital is a private equity fund management company under Tigermed. It focuses on investments in CRO M&A and early-stage startups in new drug development. The firm has made 14 investments, including a Series A investment in Spruce on August 08, 2024.
General information
Firm type
Private Equity
Year founded
2011
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: